This article is more than 5 years old. Information may no longer be current.
AACR presents achievement award
Click Here to Manage Email Alerts
The American Association for Cancer Research presented Philip S. Low, PhD, with the ninth annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research.
Low is the Ralph C. Corley distinguished professor of chemistry and director of the Center for Drug Discovery at Purdue University in West Lafayette, Indiana. He also is a founder and chief science officer of two biopharmaceutical companies, Endocyte Inc. and On Target Laboratories LLC.
The AACR and its Chemistry in Cancer Research Working Group established the award in 2007 to recognize the importance of chemistry to advancements in cancer research. The award is given for outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research, translational cancer research, cancer diagnosis, the prevention of cancer, or the treatment of patients with cancer.
Low is being recognized for his pioneering development of low–molecular-weight ligands to deliver attached therapeutic and imaging agents selectively into pathologic cells such as cancer cells. This targeted therapeutic approach improves potency and reduces toxicity.
Low’s research on low–molecular-weight ligand-targeted therapeutic and imaging agents has yielded more than 40 U.S. patents or patents pending.